Global Continuous Blood Glucose Monitoring Market Growth Analysis Forecast 2024 - 2033
1 May, 2024
The continuous blood glucose monitoring market saw rapid growth, increasing from $8.09 billion in 2023 to $9.68 billion in 2024, with a CAGR of 19.7%. This growth was fueled by the rise in diabetes prevalence, regulatory compliance, demand for remote monitoring, emerging markets, and increased healthcare spending. Looking ahead, the market is poised for exponential growth, reaching $20.44 billion in 2028, with a CAGR of 20.5%. Factors driving this growth include the growing aging population, expansion of home healthcare, telehealth expansion, increased healthcare expenditure, and rising disposable income. Major trends expected in the forecast period include wearable integration, artificial intelligence and machine learning, advanced sensors and accuracy, and partnerships and collaboration.
Major Driver In The Continuous Blood Glucose Monitoring Market
The continuous blood glucose monitoring market is expected to witness expansion driven by the growth in the prevalence of diabetes globally. Estimates from the International Diabetes Federation project a surge in the diabetic population to 643 million by 2030 and further to 783 million by 204With approximately 537 million adults living with diabetes in 2021, the escalating prevalence of diabetes is poised to fuel the growth of the continuous blood glucose monitoring market throughout 2023, 2024, and 2028.
Request A Free Sample Of The Global Continuous Blood Glucose Monitoring Market ReportGlobal Continuous Blood Glucose Monitoring Market Competitive Landscape
F. Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic plc., Abbott Laboratories, GlySens Inc., Arkray, Senseonics Holdings Inc., Glysure Limited, Nemaura Medical Inc., Tandem Diabetes Care Inc., Goldsite Diagnostics Inc., AgaMatrix Inc., B. Braun Melsungen AG, Ypsomed Holding AG, Terumo Corporation, Orsense Ltd., Dexcom Inc., A. Menarini Diagnostics, Echo Therapeutics Inc., Johnson & Johnson Services Inc., Ascensia Diabetes Care Holdings AG, Insulet Corporation, Medtrum Technologies Inc., Texas Instruments Inc., Beta Bionics Inc., Bigfoot Biomedical Inc., One Drop Inc., DarioHealth Corp., MedAngel BV, GluSense Ltd., PKvitality, Nemotecnia S.A.
Key Continuous Blood Glucose Monitoring Market Trend
Technological advancements are driving the continuous blood glucose monitoring market, with companies like Philips developing non-invasive monitors for conditions like COPD using ExpiraFlow technology. These monitors aid in expiratory flow limitation detection and optimal home care therapy.
Get The Full Global Continuous Blood Glucose Monitoring Market Report
Continuous Blood Glucose Monitoring Market Segmentation
The global continous blood glucose monitoring market covered in this report is segmented –
1) By Component: Insulin Pumps, Sensors, Transmitters, Receivers
2) By Application: Type 1 Diabetic Patients, Type 2 Diabetic Patients, Gestational Diabetes, Critical Care Patients
3) By End User: Hospitals, Homecare Diagnostics, Other End Users
By Geography:The regions covered in the continous blood glucose monitoring market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
North America was the largest region in the continuous blood glucose monitoring market in 2023.
The Continous Blood Glucose Monitoring Global Market Report 2024 furnishes information about the global continous blood glucose monitoring market, encompassing details like market size, projections for growth, segmentation across various sectors and regions, and an overview of competitors, including their revenues, profiles, and market shares. Furthermore, the report pinpoints potential opportunities and strategic directions derived from market trends and the strategies adopted by key competitors. The report also offers an assessment of how the COVID-19 pandemic, the Russia-Ukraine conflict, and increasing inflation have affected both global and regional markets, furnishing valuable strategic insights for businesses.